United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA

Published on :

United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) today announced the submission of a [….]